How long does risk-reducing removal of the ovaries and tubes take to work for a BRCA gene mutation?

Risk-reducing salpingo-oophorectomy removes both ovaries and fallopian tubes. For someone with a BRCA1 or BRCA2 mutation, it is used to reduce the risk of ovarian, fallopian tube and related abdominal cancers. The operation does not remove every possible cancer risk, and pathology results may guide further care.

The risk-reduction mechanism begins when the organs are removed. Recovery is a separate process: abdominal soreness, tiredness and activity restrictions may last for a while. If the ovaries were still producing hormones, removal can cause an abrupt menopause. Hot flushes, sleep or mood changes, vaginal symptoms and bone or heart-health questions should be discussed before and after surgery.

Discuss the timing of surgery with a gynaecologic oncology team and genetic counsellor, including fertility, contraception, menopause care and whether hormone therapy may be suitable. Ask how the operation will be performed, what recovery help you need and when pathology will be reviewed. Avoid heavy lifting until cleared, care for incisions as instructed and keep follow-up appointments.

Contact the surgical team for fever, worsening abdominal pain, increasing redness or drainage, persistent vomiting, difficulty passing urine or heavy vaginal bleeding. Seek urgent care for fainting, severe breathlessness, chest pain or a swollen painful leg. New persistent abdominal swelling, pain or changes in bowel habits should also be assessed during follow-up.

How does my BRCA1 or BRCA2 result affect the timing of this operation? What will happen to fertility and menopause symptoms? Is hormone therapy appropriate for me? What follow-up remains after the ovaries and tubes are removed? When should pathology results be available?